Biomatter is a synthetic biology company that creates new proteins for health and sustainable manufacturing applications.
Biomatter has raised $7.1M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Biomatter's investors include Inventure, Practica Capital, UVC Partners, Metaplanet, 70Ventures.
Biomatter is headquartered in Vilnius, Lithuania.
Biomatter is a synthetic biology company that creates new proteins for health and sustainable manufacturing applications.
Biomatter is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biomatter — Funding & Investors." VCBacked, August 5, 2024, https://www.vcbacked.co/company/biomatter. Accessed October 29, 2026.
VCBacked. (2024). Biomatter — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/biomatter
{{cite web |title=Biomatter — Funding & Investors |url=https://www.vcbacked.co/company/biomatter |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated